Walleye Trading
TBRA

Walleye Trading’s Tobira Therapeutics, Inc. Common Stock TBRA Stock Holding History

Walleye Trading’s Portfolio TBRA Stock Details TBRA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q4 		– Sell
-200
Closed -$2K – 6065
2015
Q3 		$2K Buy
+200
New +$2.81K ﹤0.01% 4799

Other funds holding TBRA

FM
Frazier Management Seattle, Washington $1.12M AUM 151.58% 1-Year Est. Return
NHAS
Novo Holdings A/S Hellerup, Denmark $1.23B AUM 81.32% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
SCM
Stonepine Capital Management Bend, Oregon $250M AUM 77.6% 1-Year Est. Return
SM
Sabby Management Miami Beach, Florida $45.1M AUM 74.25% 1-Year Est. Return
A
Abingworth London, United Kingdom $307M AUM 93.47% 1-Year Est. Return
EAM
EverPoint Asset Management Stamford, Connecticut $5.38B AUM 21.45% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
SFM
Sphera Funds Management Tel Aviv, Israel $630M AUM 108.65% 1-Year Est. Return

Walleye Trading's TBRA Position: Q4 2015 in Review

Walleye Trading sold out of Tobira Therapeutics, Inc. Common Stock (TBRA) in Q4 2015, closing a stake of 200 shares — an estimated $2K sold.

Walleye Trading first reported a position in TBRA in Q3 2015 and held it in 1 quarter. The position peaked at $2K in Q3 2015. 48 funds tracked by Wall St. Rank hold TBRA as of Q4 2015.

  • Walleye Trading reported no remaining Tobira Therapeutics, Inc. Common Stock position as of Q4 2015 after selling out during the quarter.
  • Walleye Trading sold 200 Tobira Therapeutics, Inc. Common Stock shares in Q4 2015, an estimated $2K.
  • Walleye Trading first reported a position in Tobira Therapeutics, Inc. Common Stock in Q3 2015 and held it in 1 quarter.
  • Walleye Trading's Tobira Therapeutics, Inc. Common Stock position peaked at $2K in Q3 2015.
  • 48 funds tracked by Wall St. Rank held Tobira Therapeutics, Inc. Common Stock as of Q4 2015.

Based on Walleye Trading's 13F filing for Q4 2015, filed 16 Feb 2016.